Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis
Sponsor: Baylor Research Institute